Seroprevalence of Human T-lymphotropic virus type-1 and -2 infections among first-time United States Blood Donors 2000-2009
© Chang et al; licensee BioMed Central Ltd. 2014
Published: 7 January 2014
Human T-lymphotropic virus types 1 and 2 (HTLV-1 and –2) are prevalent at low-level among United States blood donors, but recent data on their prevalence is lacking.
Data on all first-time blood donors in a large network of United States blood centers was examined during the period 2000-2009. Anti-HTLV-1 and -2 was measured by enzyme immunoassay (EIA) screening with type-specific confirmation by immunofluorescence or RIBA. Prevalence and odds ratios (OR) and 95% confidence intervals (CI) for associations with demographic characteristics were assessed using multivariable logistic regression.
Among 2,047,740 first-time donors, 104 donors were seropositive for HTLV-I (prevalence 5.1 (95% CI: 4.1 - 6.1) per 100,000) and 300 donors were seropositive for HTLV-2 infection (prevalence 14.7 (95% CI 13.0 - 16.3) per 100,000). Prevalence was lower than reported in the 1990’s but stable from 2000 to 2009. HTLV-1 seropositivity was associated with female sex (OR = 1.56, 95% CI 1.05-2.32); older age; and Black (IR = 25.29, 9% CI 13.14- 48.68) and Asian (OR = 21.43, 95% CI 10.31-44.53) race/ethnicity. HTLV-2 seropositivity was associated with female sex (OR = 2.13, 95% CI 1.67-2.73); older age; and non-white race/ethnicity; residence in the Western (OR=4.12, 95% CI 2.16-7.82) and Southwestern (OR=2.47, 95% CI 1.28-4.78; both vs. Northern) U.S.; and lower educational level.
HTLV-1 and -2 prevalences among U.S. blood donors declined since the early 1990’s but were stable since 2000. Higher prevalence of HTLV-2 in the West and Southwest may be attributed to endemic foci among Amerindians.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.